Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Evaluation of flurbiprofen urinary ratios as in vivo indices for CYP2C9 activity.

Evaluation of flurbiprofen urinary ratios as in vivo indices for CYP2C9 activity. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Evaluation of flurbiprofen urinary ratios as in vivo indices for CYP2C9 activity. Abstract Text:

    n k zgheibN K Zgheib,r f fryeR F Frye,t s tracyT S Tracy,m romkesM Romkes,r a branchR A Branch,

    AIMS: We investigated flurbiprofen pharmacokinetics in 12 volunteers to develop a phenotypic trait measure that correlates with the fractional clearance to 4'-hydroxyflurbiprofen. The effect of the CYP2C9 inhibitor fluconazole on flurbiprofen metabolism was also evaluated. METHODS: Flurbiprofen pharmacokinetics were evaluated before and after the first and seventh doses of fluconazole. The urinary recovery ratio was calculated as FLRR = 4'-OHF/[4'-OHF + F(tot)] and the urinary metabolic ratio was calculated as FLMR = 4'-OHF/F(tot), where 4'-OHF and F(tot) represent total (conjugated and unconjugated) amounts recovered in urine. RESULTS: There was a statistically significant relationship between the 4'-OHF formation clearance (4OHCLf) and both the 8-h FLRR and the 8-h FLMR with and without administration of fluconazole. The flurbiprofen apparent oral clearance (CL/F) was decreased by 53% [90% confidence interval (CI) -58, -48] and 64% (90% CI -69, -59), respectively, after administration of one and seven doses of fluconazole when compared with administration of flurbiprofen alone; similarly, the 4OHCLf decreased by 69% (90% CI -74, -64) and 78% (90% CI -83, -73), the 8-h FLRR decreased by 35% (90% CI -41, -29) and 40% (90% CI -46, -35) and the 8-h FLMR decreased by 61% (90% CI -65, -58) and 67% (90% CI -70, -63). The magnitude of decrease in CL/F and 4OHCLf was greater after seven doses compared with after one dose of fluconazole (P < 0.005). CONCLUSIONS: This study provides strong evidence that both the 8-h FLRR and the 8-h FLMR are suitable phenotypic indices for CYP2C9 activity.

    Evaluation of flurbiprofen urinary ratios as in vivo indices for CYP2C9 activity. Publishing Authors By Initials

    nk zgheibNK Zgheib,rf fryeRF Frye,ts tracyTS Tracy,m romkesM Romkes,ra branchRA Branch,

    For similar genetic phenomena: phenotype research abstracts see: genetic phenomena: phenotype research

    PUBMED ID PMID:

    MEDLINE DATE:

    Evaluation of flurbiprofen urinary ratios as in vivo indices for CYP2C9 activity. Journal Published:

    PUBLICATION TYPE: Research Support, U.S. Gov't,

    Journal: British journal of clinical pharmacology

    VOLUME: 63

    Page Numbers: 477-87

    Journal Abbreviation:

    ISSN: 0306-5251

    DAY: 19

    MONTH: 10

    YEAR: 2006

    Evaluation of flurbiprofen urinary ratios as in vivo indices for CYP2C9 activity. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 7503323

    Evaluation of flurbiprofen urinary ratios as in vivo indices for CYP2C9 activity. Keywords Mesh Terms:

    KEYWORDS: Phenotype

    MESH TERMS: urine

    Chemical & Substance for Abstract: Evaluation of flurbiprofen urinary ratios as in vivo indices for CYP2C9 activity. Information

    Substance Name: Cytochrome P-450 Enzyme System

    Registry Number: 9035-51-2

    Grant and Affiliation Information for Evaluation of flurbiprofen urinary ratios as in vivo indices for CYP2C9 activity.

    AFFILIATION: Center for Clinical Pharmacology, Department of Medicine, University of Pittsburg, Pittsburgh, PA 15219-3138, USA.

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY: United States NCRR

    GRANT: M01 RR00056

    ACRONYM: RR

    MEDLINETA: Br J Clin Pharmacol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Evaluation of flurbiprofen urinary ratios as in vivo indices for CYP2C9 activity Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News